ArticleBMC nephrology2025
First-year physical function trajectories and adverse outcomes in incident peritoneal dialysis: a prospective cohort protocol.
Article in BMC nephrology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
introductionPeritoneal dialysis (PD) is a key renal replacement therapy for end-stage kidney disease, yet early trajectories of physical function following PD initiation are heterogeneous and clinically consequential. The Peritoneal Dialysis-Physical Function (PD-PF) cohort study protocol aims to: (1) identify distinct 12‑month physical function trajectories after PD initiation; (2) develop prediction models using baseline and early follow-up data to classify patients into trajectory groups; and (3) examine associations of baseline physical function and trajectory membership with adverse clinical outcomes. METHODS AND ANALYSIS: We will enroll incident adult PD patients within 30 days after catheter placement. Assessments are scheduled at baseline (month 0) and at months 3, 6, 9, and 12, allowing a ± 4‑week window. Physical function is assessed by cardiopulmonary exercise testing, handgrip strength, five-times sit-to-stand, and 4-meter usual gait speed. Primary objective is to identify heterogeneous physical function trajectories over 12 months using multivariate group-based trajectory modeling jointly on the four physical function measures. We will then develop penalised multinomial logistic prediction models to classify trajectory membership using baseline predictors. Associations between baseline physical function and trajectory groups with adverse outcomes will be estimated using Cox proportional hazards models with prespecified covariate adjustment and Fine-Gray competing risks analyses will be performed for selected non-fatal outcomes as sensitivity analyses. ETHICS AND DISSEMINATION: The PD-PF study was approved by the institutional ethics committee (approval No. 2025LCSY082), and the study will be conducted in accordance with the principles of the Declaration of Helsinki and the Strengthening the Reporting of Observational Studies in Epidemiology guidelines. Written informed consent will be obtained from all participants. Results will be disseminated via peer‑reviewed publications and conference presentations, with deidentified data summaries shared upon reasonable request in accordance with institutional and regulatory policies. The study aims to inform risk stratification and targeted, function‑focused interventions in incident PD populations.
trial registrationRegistered Report Identifier: ChiCTR2500108025. Date of registration; 2025-08-22.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.